Cargando…

CSF and Blood Levels of GFAP in Alexander Disease

Alexander disease is a rare, progressive, and generally fatal neurological disorder that results from dominant mutations affecting the coding region of GFAP, the gene encoding glial fibrillary acidic protein, the major intermediate filament protein of astrocytes in the CNS. A key step in pathogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jany, Paige L., Agosta, Guillermo E., Benko, William S., Eickhoff, Jens C., Keller, Stephanie R., Köehler, Wolfgang, Koeller, David, Mar, Soe, Naidu, Sakkubai, Marie Ness, Jayne, Pareyson, Davide, Renaud, Deborah L., Salsano, Ettore, Schiffmann, Raphael, Simon, Julie, Vanderver, Adeline, Eichler, Florian, van der Knaap, Marjo S., Messing, Albee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Neuroscience 2015
Materias:	New Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603256/ https://www.ncbi.nlm.nih.gov/pubmed/26478912 http://dx.doi.org/10.1523/ENEURO.0080-15.2015

Ejemplares similares

GFAP expression as an indicator of disease severity in mouse models of Alexander disease
por: Jany, Paige L., et al.
Publicado: (2013)

Refining the concept of GFAP toxicity in Alexander disease
por: Messing, Albee
Publicado: (2019)

GFAP at 50
por: Messing, Albee, et al.
Publicado: (2020)

STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease
por: Hagemann, Tracy L., et al.
Publicado: (2023)

Regulation of GFAP Expression
por: Brenner, Michael, et al.
Publicado: (2021)

Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP
por: Lin, Ni-Hsuan, et al.
Publicado: (2017)

Nitric oxide mediates glial-induced neurodegeneration in Alexander disease
por: Wang, Liqun, et al.
Publicado: (2015)

The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP
por: Lin, Ni-Hsuan, et al.
Publicado: (2016)

Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation
por: Chen, Mei-Hsuan, et al.
Publicado: (2013)

A Novel Mutation in the Adult-Onset Alexander's Disease GFAP Gene
por: Zaver, Dhillon B., et al.
Publicado: (2019)

A Novel Mutation of GFAP Causing Adult-Onset Alexander Disease
por: Ciammola, Andrea, et al.
Publicado: (2019)

Genetic Ablation of Nrf2/Antioxidant Response Pathway in Alexander Disease Mice Reduces Hippocampal Gliosis but Does Not Impact Survival
por: Hagemann, Tracy L., et al.
Publicado: (2012)

Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease
por: Bachetti, Tiziana, et al.
Publicado: (2021)

GFAP canonical transcript may not be suitable for the diagnosis of adult-onset Alexander disease
por: Pinto e Vairo, Filippo, et al.
Publicado: (2018)

Adult-Onset Alexander Disease: New Causal Sequence Variant in the GFAP Gene
por: Goerttler, Tsepo, et al.
Publicado: (2022)

Effects of Alexander disease–associated mutations on the assembly and organization of GFAP intermediate filaments
por: Yang, Ai-Wen, et al.
Publicado: (2022)

A Novel GFAP Mutation in Late-Onset Alexander Disease Showing Diffusion Restriction
por: Nam, Tai-Seung, et al.
Publicado: (2017)

Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model
por: Lee, So-Hyun, et al.
Publicado: (2017)

Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity
por: Battaglia, Rachel A, et al.
Publicado: (2019)

Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease
por: LaPash Daniels, Christine M., et al.
Publicado: (2015)

Tissue and cellular rigidity and mechanosensitive signaling activation in Alexander disease
por: Wang, Liqun, et al.
Publicado: (2018)

Activation of a Cryptic Splice Site of GFAP in a Patient With Adult-Onset Alexander Disease
por: Amano, Eiichiro, et al.
Publicado: (2021)

Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes
por: Jones, Jeffrey R., et al.
Publicado: (2018)

GFAP variant p. Tyr366Cys demonstrated widespread brain cavitation in neonatal Alexander disease.
por: Takeuchi, Hirokazu, et al.
Publicado: (2021)

A novel three-base duplication, E243dup, of GFAP identified in a patient with Alexander disease
por: Yasuda, Rei, et al.
Publicado: (2017)

Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter
por: van der Voorn, J. Patrick, et al.
Publicado: (2009)

Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes
por: Boyd, Michelle M., et al.
Publicado: (2021)

Functional characterization of a GFAP variant of uncertain significance in an Alexander disease case within the setting of an individualized medicine clinic
por: Boczek, Nicole J., et al.
Publicado: (2016)

Mitochondria Are Dynamically Transferring Between Human Neural Cells and Alexander Disease-Associated GFAP Mutations Impair the Astrocytic Transfer
por: Gao, Longfei, et al.
Publicado: (2019)

Identification of a novel de novo pathogenic variant in GFAP in an Iranian family with Alexander disease by whole-exome sequencing
por: Heshmatzad, Katayoun, et al.
Publicado: (2022)

Alexander disease GFAP R239C mutant shows increased susceptibility to lipoxidation and elicits mitochondrial dysfunction and oxidative stress
por: Viedma-Poyatos, Álvaro, et al.
Publicado: (2022)

Type II (adult onset) Alexander disease in a paraplegic male with a rare D128N mutation in the GFAP gene
por: Chang, Ki-Eun, et al.
Publicado: (2015)

Alexander Disease: Report of Two Unrelated Infantile Form Cases, Identified by GFAP Mutation Analysis and Review of Literature; The First Report from Iran
por: Ashrafi, Mahmoud-Reza, et al.
Publicado: (2013)

Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant
por: Melchionda, Laura, et al.
Publicado: (2013)

Epileptic Encephalopathy Due to BRAT1 Pathogenic Variants
por: Srivastava, Siddharth, et al.
Publicado: (2016)

Therapy Trial Design in Vanishing White Matter: An Expert Consortium Opinion
por: van der Knaap, Marjo S., et al.
Publicado: (2022)

Fanny & Alexander
Publicado: (2008)

The Alexander technique /
por: Barlow, Wilfred
Publicado: (1974)

Alexander Nevsky /
por: Prokofiev, Sergey, 1891-1953
Publicado: (1989)

Alexander Miles
Publicado: (1953)

Cannot write session to /tmp/vufind_sessions/sess_tastgcv4s95g7qudcuvfaq9g0v